Acuamark Diagnostics, Inc. — Form D
Acuamark Diagnostics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-04. The offering totals $12.0M, of which $4.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-06-04
- Form: D
- Accession: 0001685619-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $4.9M
- Remaining: $7.1M
- Investors: 20
- Date of first sale: 2024-05-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515110
Issuer
- Name: Acuamark Diagnostics, Inc.
- CIK: 0001685619
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 101 AVENUE OF THE AMERICAS, NEW YORK, NY, 10020
- Phone: 646-640-7865
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Claudio Del Vecchio | Director | New York, NY |
| Cedric Francois | Director | Crestwood, KY |
| William Gedale | Director | New York, NY |
| Giulia Kennedy | Director | New York, NY |
| Bernard Peperstraete | Director | New York, NY |
| Vanja Vuletic | Director | New York, NY |
| Bernard Peperstraete | Executive Officer | New York, NY |
| Joseph Smith | Director | Morro Bay, CA |
| Bernard Peperstraete | Promoter | New York, NY |
| Howard Johnson | Director | New York, NY |
| Gregory Murdock | Director | New York, NY |
| Michael Gargano | Director | JUPITER, FL |
| BRIAN CARR | Director | NEW YORK, NY |
| Michael Hanbury | Director | New York, NY |
| David Weavil | Director | New York, NY |
Other filings by this issuer (3)
More